Beyond two-dimensional cell cultures, chronic RSK inhibitor treatment could achieve effective suppression of melanoma growth also in different three-dimensional in vitro model systems simulating more physiological growth conditions. The gene discussed is RPS6KA3; the disease is melanoma.